Traceability in Laboratory Medicine: What is it and Why is it Important for Patients? [0.03%]
检验医学中的可追溯性及其对患者的重要意义是什么？
Graham H Beastall
Graham H Beastall
The between method variability of patient results is a source of uncertainty that can have adverse consequences for patient safety and clinical outcomes. Globalisation requires that laboratory medicine results should be transferable between...
János Kappelmayer
János Kappelmayer
Editorial
EJIFCC. 2018 Dec 5;29(4):241. DOI: 2018
Criteria for specific measurement of plasminogen (enzymatic; procedure) in human plasma [0.03%]
人血浆中特定测量纤溶酶原(酶法;程序)的指标
Johannes J Sidelmann,Nuala A Booth,Johannes Hoffmann et al.
Johannes J Sidelmann et al.
There is a lack of well-established criteria for the specific measurement of fibrinolytic variables. On behalf of the SSC the Subcommittee on Fibrinolysis started a process to develop such criteria. This report describes the criteria for th...
Review
EJIFCC. 2000 Sep 1;12(3):83-91. DOI: 2000
The Clinical Value of Assays of Fibrin Degradation Products, and Their Use in the Netherlands [0.03%]
纤维蛋白降解产物检测的临床价值及其在荷兰的应用
W Nieuwenhuizen
W Nieuwenhuizen
Information about the status of the haemostatic balance can be derived from the end products of coagulation and fibrinolysis, i.e. soluble fibrin and fibrin degradation products (FbDP), such as D-dimer, respectively. Assays for FbDP have be...
Cecilia Karlsson
Cecilia Karlsson
The hopes of millions of obese persons were raised in 1994 when the "fat-melting" hormone leptin was discovered by Friedman and colleagues. Primary experiments on the adipose-tissue-derived hormone leptin seemed very promising and gave new ...
Adipose tissue [0.03%]
脂肪组织
Per Björntorp
Per Björntorp
Review
EJIFCC. 2000 Sep 1;12(3):68-72. DOI: 2000
Inter-Laboratory Exchange of Knowledge and Technology Around our Sea - A Lab Surfing Project [0.03%]
围绕我们的海洋开展的实验室间知识和技术交流——“实验室冲浪”项目
Guilaine Boursier
Guilaine Boursier
Josep Miquel Bauça
Josep Miquel Bauça